LY2623091

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY2623091, covering 2019-06-03 to 2020-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2623091 in Participants With High Blood Pressure [Phase 2]